PHARMANUTRA S.P.A.: NEW LICENCE GRANTED IN THE U.S.A.
/PRNewswire/ -- PharmaNutra S.p.A. (MTA; Ticker PHN), a company specialising in mineral- and iron-based nutritional supplements and medical devices for muscles...
Stay updated with breaking news from Gianluca Gracci. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- PharmaNutra S.p.A. (MTA; Ticker PHN), a company specialising in mineral- and iron-based nutritional supplements and medical devices for muscles...
/PRNewswire/ -- Since 2003, the scientific research activity of PharmaNutra (MTA; Ticket PHN), a group of companies specialized in the development, production...
Press release content from PR Newswire. The AP news staff was not involved in its creation.
ApportAL® (PRNewsfoto/PharmaNutra S.p.A.) Quality of life and degree of fatigue were measured for each patient at 0, 14 and 28 days, while taking the supplement. The FACIT-Fatigue questionnaire was used to assign an objective fatigue value to the long-COVID patients. It is made up of 13 statements relating to ability to perform everyday tasks, sleep needs during the day, energy and tiredness. A second questionnaire created by re-adapting the Chalder Fatigue Scale was used to assess mental fatigue. These questions asked about memory, ability to concentrate and interest in activities performed...
Press release content from PR Newswire. The AP news staff was not involved in its creation. The American FDA Awards The Cetylated Esters Patented By PharmaNutra Gras Substance Recognition December 23, 2020 GMT PharmaNutra Logo PISA, Italy, Dec. 23, 2020 /PRNewswire/ -- PharmaNutra S.p.A. (the “Company”), specialised in iron-based nutritional supplements and in medical devices for muscles and joints, communicates that its patented Cetylated Esters (CFA) has been recognized as GRAS (acronym for Generally Recognized As Safe)for the U.S. market. Germano Tarantino, Scientific Director of Pharm...